Chemicals and Materials Antimicrobial Plastic Market New | Page 2

H1N1 and nosocomial infections in the recent past. As a result, the importance of
antimicrobial plastics in medical and healthcare application is expected to increase during
the forecast period. Moreover, innovation in the medical and healthcare application, for
instance, the development of non-toxic plastic equipment is anticipated to fuel the growth
of the antimicrobial plastics market. Surgical and medical devices such as catheters, cubicle
curtains, beds, and dental implants are the other medical and healthcare applications of
antimicrobial plastics.
APAC is estimated to account for the largest share of the antimicrobial plastics
market during the forecast period
APAC is the largest and fastest-growing antimicrobial plastics market. Growing
industrialization, backed by infrastructure development in the region, has offered
enormous opportunities for the use of antimicrobial plastics in APAC. The growing demand
and policies, such as emission control and use of environmentally-friendly products, have
led to innovation in the plastics industry of the region, making it a plastics hub, globally.
The growing population, along with industry alliances, is expected to lead to significant
growth of the antimicrobial plastics market in the region.
For more information, download PDF brochure at,
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20591555
The leading players in the market include the BASF SE (Germany), Bayer MaterialScience AG
(Germany), The Dow Chemical Company (U.S.), Clariant AG (Switzerland), Lonza Group AG
(Switzerland), Microban International (U.S.), Parx Plastic BV (The Netherlands), King Plastic
Corporation (U.S.), Biocote (U.K.), Milliken Chemical (U.S.), Sanitized AG (Switzerland), and
PolyOne Corporation (U.S.).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000
companies as clients. Almost 75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth
markets following the "Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most important
customers, write "Attack, avoid and defend" strategies, identify sources of incremental
revenues for both the company and its competitors. MarketsandMarkets™ now coming up